{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:17:05Z","timestamp":1784945825172,"version":"3.55.0"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ajem.2020.09.030","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T01:27:16Z","timestamp":1600306036000},"page":"263.e5-263.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Ocular timolol as the causative agent for symptomatic bradycardia in an 89-year-old female"],"prefix":"10.1016","volume":"42","author":[{"given":"John","family":"Rains","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Kesterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ajem.2020.09.030_bb0005","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00417-002-0462-2","article-title":"Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops","volume":"240","author":"Korte","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5\u20136","key":"10.1016\/j.ajem.2020.09.030_bb0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00228-005-0945-2","article-title":"Association between low plasma levels of ophthalmic timolol and haemodynamics in glaucoma patients","volume":"61","author":"Nieminen","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ajem.2020.09.030_bb0015","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/bmj.332.7547.960","article-title":"Syncope and falls due to timolol eye drops","volume":"332","author":"M\u00fcller Marije","year":"2006","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ajem.2020.09.030_bb0020","first-page":"699","article-title":"Bradycardia and congestive heart failure associated with ophthalmic timolol maleate","volume":"38","author":"Linkewich","year":"1981","journal-title":"Am J Hosp Pharm"},{"issue":"2","key":"10.1016\/j.ajem.2020.09.030_bb0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/00365510601034736","article-title":"Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects","volume":"67","author":"Nieminen","year":"2007","journal-title":"Scand J Clin Lab Invest"},{"issue":"2","key":"10.1016\/j.ajem.2020.09.030_bb0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ajem.2020.09.030_bb0035","series-title":"Table 3\u20132: Examples of clinical inhibitors for P450-mediated metabolisms","author":"Center for Drug Evaluation and Research","year":"2020"},{"key":"10.1016\/j.ajem.2020.09.030_bb0040","unstructured":"Cytochrome P-450 CYP2D6 inhibitors (strong), DrugBankwww.drugbank.ca\/categories\/DBCAT002624"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567572030824X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567572030824X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:53:20Z","timestamp":1760025200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073567572030824X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":8,"alternative-id":["S073567572030824X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2020.09.030","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular timolol as the causative agent for symptomatic bradycardia in an 89-year-old female","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2020.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}